SLC19A3 Back

solute carrier family 19, member 3

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of SLC19A3

This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild mental retardation, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.

Community Annotation of SLC19A3 Add / Edit SLC19A3: Annotations

No community annotations yet for SLC19A3.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes

• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


SLC19A3 is highly significantly mutated in
SLC19A3 is significantly mutated in
SLC19A3 is near significance in

Click on a tumor type to see its full list of significant genes.

Data details

Mutation list for SLC19A3